Curoverse Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
Curoverse General Information
Description
Provider of genomic and biomedical computing platform intended to empower scientists and clinicians to focus on making breakthrough discoveries and delivering real-world care. The company's genomic and biomedical computing platform enables patient-level genomic and health data to be securely accessible for drug development and precision medicine, enabling scientists and clinicians to manage, process, analyze and share massive biomedical data sets for everything from genomics to imaging.
Contact Information
Website
www.curoverse.comCorporate Office
- 212 Elm Street
- 3rd Floor
- Somerville, MA 02144
- United States
Corporate Office
- 212 Elm Street
- 3rd Floor
- Somerville, MA 02144
- United States
Curoverse Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 03-Aug-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 24-Mar-2015 | $1.5M | $3.2M | Completed | Startup | |
| 1. Seed Round | 18-Feb-2014 | $1.7M | $1.7M | Completed | Startup |
Curoverse Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series Seed |
Curoverse Comparisons
Industry
Financing
Details
Curoverse Competitors (5)
One of Curoverse’s 5 competitors is Verogen, a Formerly PE-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verogen | Formerly PE-Backed | San Diego, CA | ||||
| Eagle Genomics | Formerly VC-backed | London, United Kingdom | ||||
| AMPED PCR | Venture Capital-Backed | Aberystwyth, United Kingdom | ||||
| BC Platforms | Private Equity-Backed | Zurich, Switzerland | ||||
| Flatiron | Formerly VC-backed | New York, NY |
Curoverse Signals
Curoverse Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boston Global Ventures | Venture Capital | Minority | ||
| Converge Venture Partners | Venture Capital | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority | ||
| Hyperplane Venture Capital | Venture Capital | Minority | ||
| MassVentures | Venture Capital | Minority |
Curoverse FAQs
-
When was Curoverse founded?
Curoverse was founded in 2010.
-
Where is Curoverse headquartered?
Curoverse is headquartered in Somerville, MA.
-
What is the size of Curoverse?
Curoverse has 15 total employees.
-
What industry is Curoverse in?
Curoverse’s primary industry is Business/Productivity Software.
-
Is Curoverse a private or public company?
Curoverse is a Private company.
-
What is Curoverse’s current revenue?
The current revenue for Curoverse is .
-
How much funding has Curoverse raised over time?
Curoverse has raised $3.2M.
-
Who are Curoverse’s investors?
Boston Global Ventures, Converge Venture Partners, Hatteras Venture Partners, Hyperplane Venture Capital, and MassVentures are 5 of 6 investors who have invested in Curoverse.
-
Who are Curoverse’s competitors?
Verogen, Eagle Genomics, AMPED PCR, BC Platforms, and Flatiron are competitors of Curoverse.
-
When was Curoverse acquired?
Curoverse was acquired on 03-Aug-2017.
-
Who acquired Curoverse?
Curoverse was acquired by Veritas (Laboratory Services).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process